Over the last decade, systemic cancer therapies have evolved to exploit the growing knowledge of molecular aberrations involved in the development and progression of lung cancer. This review highlights the biological targets relevant in the treatment of non-small cell lung cancer.
- Epidermal growth factor receptor
- Non-small cell lung cancer
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine